次世代がん医療加速化研究事業

  • 次世代がん医療加速化研究事業

    分担研究者:東北大学 加藤幸成(代表:徳島大学 西岡安彦
    令和7年度〜令和9年度
    課題名:腫瘍内fibrocyteが担う新規免疫排除機構:標的分子の同定から抗体医療への展開

    ・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・・

    <文献>
    4. Li G, Suzuki H, Kaneko MK, Kato Y.
    Establishment of novel anti-EphB3 monoclonal antibodies for multiple applications
    Monoclon Antib Immunodiagn Immunother, 45(1-2), 1–10, https://doi.org/10.1177/216794362514083, 2026 (PDF; preprint; YouTube)

    3. Taruta H, Tanaka T, Kaneko MK, Suzuki H, Kato Y.
    Cx2Mab-5: a Novel anti-mouse CXCR2 monoclonal antibody developed by N-terminus peptide Immunization for multiple applications
    Monoclon Antib Immunodiagn Immunother, 45(1-2), 11–20, https://doi.org/10.1177/2167943625141526, 2026 (PDF; preprint; YouTube)

    2. Li G, Suzuki H, Kaneko MK, Kato Y.
    A novel anti-Cadherin 19 monoclonal antibody (Ca19Mab-8) for flow cytometry, Western blotting, and immunohistochemistry
    cimb-4183612, 48(3), 307; https://doi.org/10.3390/cimb48030307, 2026 (PDF; preprint)

    1. Ubukata R, Suzuki H, Kaneko MK, Kato Y.
    Development of novel anti-CDH1/E-cadherin monoclonal antibodies for flow cytometry, western blotting, and immunohistochemistry
    BBREP, 45, 102401, https://www.sciencedirect.com/science/article/pii/S2405580825004881, 2026 (PDF; preprint)